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meshwork protease proteome
Renata Picciani, Anna K. Junk, Sanjoy K. Bhattacharya
Bascom Palmer Eye Institute, University of Miami, Miami, FL
We present a novel and simple enrichment strategy to capture trabecular meshwork (TM) protease proteome. The method
relies on fractionation of TM tissue into cytosolic and nuclear extracts and subsequent affinity enrichment of proteases
on peptide inhibitors. A large repertoire of available protease substrate analog peptides enables an improved capture of
TM protease proteome compared to SDS–PAGE fractionation alone. Peptide analog inhibitors of protease substrates are
immobilized on a protein A or G column using 254 nm intense ultraviolet (UV) light. The TM cytosolic protein extract
incubated on the column is eluted with salt or a buffer with a low hydrogen ion concentration. The resultant protein solution
is precipitated with acetone, fractionated on SDS–PAGE, in situ trypsin digested, and subjected to mass spectrometry.
This relatively simple protocol enables improved capture of cytosolic proteases. We identified 20 previously reported TM
proteins from a single donor tissue using affinity enrichment. The majority of identified proteins were either intracellular
proteases or known protease inhibitors. Both serine and cysteine proteases were captured using this strategy with improved
coverage compared to our previous identification without affinity enrichment.
The glaucomas are a group of irreversible blinding optic
neuropathies that affect over 70 million people worldwide
[1]. Glaucoma is often associated with increased intraocular
pressure (IOP) leading to damage of the optic nerve. The
imbalance of aqueous humor production and outflow results
from IOP elevation. The aqueous humor is actively produced
by the ciliary body epithelium and exits the eye through the
structures of the anterior chamber angle after bathing the lens
and the cornea. The aqueous humor outflow experiences most
resistance at the level of trabecular meshwork (TM) [2]. In
open-angle  glaucoma,  poorly  understood  structural  and
functional changes in the TM such as remodeling of the TM
extracellular  matrix  (ECM)  are  associated  with  increased
resistance, which impedes the aqueous outflow [3-5]. The
ECM changes in the TM have been suggested by several
biochemical  studies  [4,6,7]  and  directly  supported  by
ultrastructural studies [5,8]. Changes and/or remodeling of the
ECM  can  occur  in  a  variety  of  ways  such  as  increased
secretion and decreased degradation of matrix proteins, cell
adhesion, migration, and changes in cell shape and number
[7,9].  Degradation  of  ECM  components  by  matrix
metalloproteases  enables  changes  in  cell  morphology,
adhesion, and migration. Increased secretion and/or secretion
of altered forms of proteins including matrix metalloproteases
are approaches employed by cells in ECM remodeling as well.
The  precise  role  of  matrix  metalloproteases  in  the  ECM
remodeling has been the subject of several studies [10-12].
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However, intracellular proteases also have the potential to
provoke ECM changes by processing expressed matrix gene
products [13,14] and modifying different forms of receptors/
transporters that are important for entry and exit of key cellular
homeostatic components such as the endothelin B receptor
[15].  However,  comprehensive  studies  in  changes  of  TM
intracellular  proteases  have  not  been  performed.  Recent
investigations  suggest  that  important  alterations  including
impairment of intracellular proteases due to posttranslational
modifications  occur  in  the  glaucomatous  TM  [6,14].  The
changes  in  the  intracellular  protease  proteome  can  be
identified  using  high-throughput  proteomic  mass
spectrometric approaches. One of the challenges in proteomic
studies  lies  in  reducing  the  complexity  in  capturing,
identifying, and eventually quantifying the proteome changes
[16]. Here, we present a simple and efficient method that
allows better capturing of TM intracellular proteases. This
method will enhance our understanding of TM intracellular
protease  changes  that  occur  as  part  of  glaucoma
pathophysiology.
METHODS
Tissue procurement: Normal eyes (Table 1) were procured
from the National Disease Research Institute (Philadelphia,
PA) and the Lions Eye Bank (Miami, FL). The eyes were
enucleated within 10 h of death, placed in a moisture chamber
at 4 °C, and transported. These eyes were dissected within 48
h, and the TM was carefully excised for study. Fresh porcine
TM tissue was isolated from freshly enucleated eyes from
euthanized  pigs  procured  from  the  University  of  Miami
Department  of  Surgery  following  IACUC  approved
protocols.
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871Preparation of cytosolic extract: TM was carefully dissected
from normal cadaver eyes. TM cytosolic and nuclear protein
extracts  were  obtained  using  the  NE-PER  Nuclear  and
Cytoplasmic  Extraction  Reagents  kit  (Cat  number  78833;
Pierce  Biotechnology,  Rockford,  IL)  and  following  the
protocols recommended by the manufacturer. The recovered
proteins were subjected to spectrophotometric quantification
using the Bradford assay and subsequently aliquoted for use
or stored at −80 °C for future analysis. All protein aliquots
were either freshly used or subjected to only one freeze–thaw
cycle.
Western blot analyses: Approximately 10 µg of total cytosolic
and nuclear protein extracts were fractionated on a 4%–20%
Tris-glycine gradient gel (Invitrogen Corporation, Carlsbad,
CA),  transferred  onto  a  polyvinylidene  fluoride  (PVDF)
membrane,  and  incubated  overnight  at  4  °C  with  the
antibodies  (~5  μg/ml)  detailed  below.  For  these  analyses,
rabbit monoclonal antibody against histone H3 (Cat number
05–928;  Upstate®,  Billerica,  MA)  and  rabbit  polyclonal
antibody against GAPDH (Cat number sc-25778; Santa Cruz
Biotechnology  Inc.,  Santa  Cruz,  CA)  were  used.
Subsequently, a 2 h incubation at 4 °C with the appropriate
horseradish peroxidase secondary antibodies was performed.
All  incubations  occurred  in  5%  milk.  Detection  was
performed  using  electrochemiluminescence  (ECL;  catalog
number 32106; Pierce Biotechnology, Rockford, IL).
Preparation of enrichment column and capture of proteases:
The enrichment column was prepared by ultraviolet (UV)
cross-linking  of  peptides  present  in  commercial  protease
inhibitor cocktails. Two different protease inhibitors (100 µl
each; Protease inhibitor cocktail for use with mammalian cell
and tissue extracts and Sigma Fast Protease inhibitor tablets
for general use, Cat number P8340 and S8820, respectively;
Sigma-Aldrich Inc., St. Louis, MO) were incubated with 200
µl  (2.5  mg)  of  Protein  A  Sepharose  beads  (Cat  number
170780–01; Amersham Biosciences, Piscataway, NJ) for 15
min and subsequently UV cross-linked for 90 s at 120 mJ/
cm2 in a UV transilluminator equipped with 254 nm bulbs. A
cytosolic protein extract was added (~250 µg) and incubated
for 1 h at 4 °C with gentle shaking. For the controls, no
protease inhibitor was added to the sample (two different
protease  inhibitor  cocktails,  which  slightly  differ  in  their
TABLE 1. DONOR DETAILS.
Age Race Gender Time of death to
enucleation (h)
55 W M 8
53 W M 7
62 W F 10
76 W F 9
55 W M 9
The Caucasian race is indicated by W. Letters M and F denote
male and female, respectively.
composition of inhibitory peptides, were used to rule out the
possibility that the capture of proteases is not vastly different
between the two). A 2 ml column (Cat number 89896; Pierce
Biotechnology, Rockford, IL) was equilibrated with 1 ml 1X
PBS. The samples were passed through the column three times
and then washed with 250 µl 1X PBS twice. Subsequently,
100 µl of 1 M NaCl plus 100 mM KCl were used for elution.
Finally,  the  elution  products  were  subjected  to  acetone
precipitation with the addition of four volumes of cold acetone
and to incubation at room temperature for 15 min with or
without  carrier  tRNA  (Yeast  tRNA;  Catalog  number
15401029; Invitrogen Inc., Carlsbad, CA). Carrier tRNA was
added  to  enhance  the  capture  of  proteins  during  acetone
precipitation. The samples were then centrifuged at 12,000
rpm for 20 min. The supernatant was discarded, and the pellet
was resuspended in 5 µl of water.
Gel electrophoretic fractionation and mass spectrometry: The
fractionation of elution products was performed either on a
4%–20% Tris-glycine gradient gel (Invitrogen Corporation,
Carlsbad, CA) or on a 4%–15% gradient PHAST gel (Cat
number  17–0678–01;  GE  Healthcare  Biosciences  Corp,
Piscataway, NJ). The gel was subjected to Coomassie Blue
staining  followed  by  SyproRuby  Protein  Gel  Stain  (Cat
number S12001; Invitrogen Corporation, Carlsbad, CA) and
silver  staining  (Pro-Pure  protein  assay,  Cat  number
M2271Lkit; AMRESCO Inc., Solon, Ohio). Approximately,
10 µg of the TM protein extracts (total cytosolic and nuclear
extract) was also loaded on the 4%–20% Tris-glycine gel. On
4%–15%  PHAST  gel,  4  µg  of  cytosolic  extract  was  also
loaded in addition to eluents.
For  mass  spectrometric  identification  of  proteins,  gel
slices were excised and digested in situ with sequencing grade
porcine trypsin (Promega Biosciences Inc., San Luis Obispo,
CA). The products of in situ digestion were loaded onto pre-
columns 360 mm od x 100 mm id fused silica (Polymicro
Technologies, Phoenix, AZ) packed with 3 cm of irregular 5–
15 µm-non-spherical C18 (YMC Inc., Wilmington, NC). The
column was washed with 0.1 M acetic acid (AcOH) for 5 min
before switching in-line with the resolving column (7-cm
spherical C18, 360 od x 100 id). Once the columns were in-
line, the peptides were gradient eluted with a 0%–100% B in
30 min where A was 0.1 M AcOH in nanopure water and B
was  0.1  M  AcOH  in  80%  acetonitrile.  All  samples  were
analyzed using a Thermo Electron Finnigan LTQ (San Jose,
CA).  Electrospray  was  accomplished  using  an  Advion
Triversa Nanomate (Advion Biosystems, Ithaca, NY) with a
voltage of 1.7 kV and a flow rate of 250 nl/min. The mass
spectrometer was operated in data dependent mode with the
top five most abundant ions in each spectrum being selected
for  sequential  tandem  mass  spectrometry  (MS/MS)
experiments. The exclusion list was used (1 repeat, 180 s
return  time)  to  increase  the  dynamic  range.  All  MS/MS
spectra  were  searched  with  Sequest  version  2.7
(ThermoFinnigan, San Jose, CA) and Mascot using NCBI
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872non-redundant,  Ensemble,  and  SwissProt  databases.  The
search  of  database  entries  were  restricted  to  Human  and
Metazoa (animals) and allowed for a maximum of two missed
cleavages.  The  protonated  molecule  ions  “MH+”  and
“Monoisotopic” were defined for the peak mass data input.
The SEQUEST Sp and Xcorr cutoff scores of the protonated
“MH+” peptides were 500 and 1.8, respectively. For Mascot
searches, the score was greater than 78. All spectra were
visually  inspected  for  determination  of  correct  database
assignment. The potential chemical modifications of a peptide
such  as  alkylation  of  a  cysteine  (carbamidomethyl  [C]),
oxidation of a methionine residue (M), and acetylation of a
lysine (K) were also considered in the search. No restrictions
were imposed for either the protein isoelectric point or the
molecular weight during the search.
RESULTS
Enrichment  of  proteins  in  immobilized  protease  inhibitor
peptide columns: Human TM samples were solubilized using
buffers provided in the NE-PER Nuclear and Cytoplasmic
Extraction  Reagents  kit  (Pierce  Biotechnology  Inc.)  and
subjected to fractionation into cytosolic and nuclear fractions
as described in Methods. The cytosolic fraction was subjected
to affinity enrichment for proteases over a P8340 or a S8820
peptide  inhibitor  cocktail  column.  The  column  affinity
enrichment resulted in the recovery of very small amounts of
proteins.  SDS–PAGE  fractionation  of  proteins  (4%–20%
gradient mini gels; Invitrogen Inc.) did not allow detection of
protein bands upon Coomassie Blue (Figure 1A) or silver
staining (Figure 1B). The same amount of eluted proteins in
a final volume of 4 µl was loaded onto a six-well PHAST gel
(GE Healthcare) and subjected to fractionation and staining.
Both Coomassie blue and silver staining allowed detection of
the eluted bands (Figure 1C,D). To ensure the fractionation of
cytosolic and nuclear proteins, the total protein, cytosolic, and
nuclear  fractions  were  subjected  to  western  blot  analyses
(Figure  1E,F).  When  the  blot  was  probed  with  antibody
against GAPDH, only total and cytosolic extracts showed
presence of GAPDH immunoreactivity (Figure 1E). On the
other hand, probing the blot with histone H3 antibody revealed
reactivity  in  the  total  and  nuclear  extracts  and  not  in  the
cytosolic extract (Figure 1F), suggesting fractionation of total
proteins into cytosolic and nuclear extracts.
Quantification of peptide column recovered proteins: The
method presented here is to enable the capture of the protease
proteome profile from single tissue samples. This method is
aimed to eventually be applied to surgical TM tissue samples.
While it is possible to quantify the proteins recovered from
immobilized peptide columns with established biochemical
methods for large initial protein loads (milligram quantities),
the  limited  initial  protein  load  in  actual  tissue  samples
prohibits quantification with the current biochemical methods
(i.e., Bradford, Folin-Ciocalteau, Lowry, and Amido Black).
For  this  purpose,  we  have  performed  experiments  with
porcine TM tissue to reduce or limit the use of precious human
tissue for method development alone. Our studies indicate that
reproducible  relative  quantification  is  possible  for
fractionated proteins on the PHAST gel system using silver
staining and densitometry, but absolute quantification is not.
Using porcine TM extract and densitometric scans of silver
staining, the impact of the initial material (within a range of
50–500 µg) and time of incubation (1–16 h) was found to have
an effect on the relative recovery of proteins (Figure 2). The
densitometric scan of the recovered products from 550 µg of
initial TM extract was incubated with immobilized peptide
beads for 3 h, eluted with 1 M NaCl plus 100 mM KCl
followed by acetone precipitation; 10 µg of carrier yeast tRNA
was used as a reference (considered as 100 percent). This
reference was used for calculation of the relative recovery
ratios  for  all  other  elutions.  To  determine  the  effect  of
incubation time on relative recovery of eluted products, an
initial load of 500 µg of porcine TM and was used, and elution
was performed in an identical fashion as noted above.
Enhanced recovery as a function of carrier molecules and/or
electrolyte addition: The recovery of proteins within a 50–250
µg range of initial material was found to be enhanced with the
use of carrier molecules (yeast t-RNA). The electrolytes, a
Figure  1.  Analyses  of  SDS–PAGE  fractionated  proteins  in
enrichment steps. A. About 100 µg of protein (initial load) was
subjected  to  affinity  enrichment  on  P8340  or  S8820  column  as
indicated and total eluted and acetone precipitated proteins were
subjected to SDS–PAGE fractionation and stained with Coomassie
blue. An initial load (10 µg) of total, nuclear and cytosolic proteins
were fractionated on a SDS–PAGE. For this purpose cytosolic and
nuclear fractions (10 µg proteins each) from NE-PER Nuclear and
Cytoplasmic Extraction Reagents kit (Pierce Biotechnology Inc.)
were obtained B. The same gel as in A was subjected to silver
staining. C. About 250 µg of protein (initial load) was subjected to
affinity enrichment on P8340 or S8820 column as indicated. Total
eluted  and  acetone  precipitated  proteins  were  subjected  to
fractionation on a 4%–15% PHAST gel (GE Healthcare) and stained
with Coomassie blue. D. The same gel as in C was subjected to silver
staining. The control is the cytosolic fraction (4 µg) passed through
an empty protein A column as described in methods. E. After transfer
to a PVDF membrane, western analyses of protein extracts were
performed, using GAPDH antibody and, F. Histone H3 antibody, as
described in methods.
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873combination of sodium and potassium, have an effect on the
recovery of silver stained proteins. The addition of potassium
chloride increased the recovery of proteins (data not shown).
The addition of potassium chloride and carrier tRNA also
reduced batch to batch variation in recovery especially with
low initial loads (50–250 µg).
Mass  spectrometric  identification  of  recovered  trabecular
meshwork proteases: In normal TM, a total of 20 proteins
were  identified  (Table  2).  The  majority  of  the  identified
proteins are proteases encompassing both serine and cysteine
proteases (Table 2). Several protease inhibitors such as anti-
chymotrypsin,  anti-trypsin,  and  anti-thrombin  were  also
identified (Table 2). Some non-protease proteins were also
identified (Table 2). At this point, it is not well understood
why these proteins/peptides showed strong binding. Proteases
can bind to peptides, which are not their known high affinity
substrate analog. Consequently, the TM proteases identified
by affinity enrichment may or may not have a direct peptide
inhibitor/analog. We identified all proteases from one single
TM tissue in our current analyses that were identified from
Figure 2. Effect of Initial material and time of incubation on relative
recovery of proteins from immobilized affinity peptide columns. A.
The relative recovery of protein was determined using fractionated
Porcine cytosolic proteins on a PHAST gel using silver staining and
densitometric scan of the area. The densitometric scan of product
from 550 µg of initial TM extract incubated with beads for 3 h,
recovered  using  1  M  NaCl,  100  mM  KCl  elution  after  acetone
precipitation  using  10  µg  of  carrier  yeast  tRNA  as  reference
(considered as 100 percent) was used for determination of relative
recovery ratios. B. Porcine TM extracts (500 µg initial load) was used
for incubation at different times as indicated was eluted with 1 M
NaCl and 100 mM KCl using carrier yeast tRNA. Results of three
independent determinations were used to determine the mean and
standard deviation shown here.
combined multiple numbers of TMs by proteomic analysis in
a previous study [17]. The enhancement of identification in
the current study is due to affinity enrichment of proteases.
Although the total number of intracellular proteases identified
are the same in our previous and in our current analyses (Table
2),  they  are  different  in  two  respects.  First,  all  identified
proteases are from a single TM tissue sample rather than from
multiple  TM  samples,  and  second,  all  identified  protease
peptide  matches  (coverage)  are  greater  than  our  previous
analysis.  In  the  previous  analyses,  fewer  proteases  were
identified from a single TM tissue. All the proteases enlisted
in Table 2 were identified only when six different TM samples
were combined [17]. There are some non-protease proteins
(for example, protease inhibitor anti-trypsin) for which fewer
peptides were identified in the current analysis than in our
previous  analysis.  However,  overall  a  better  capture  of
protease peptides was obtained with affinity enrichment as
described above.
DISCUSSION
Glaucoma is thought to be due to increased resistance at the
TM, which impedes aqueous humor outflow. Changes in the
ECM  are  responsible  for  the  altered  resistance.  Increased
production  of  ECM  proteins  or,  alternatively,  processed
secreted protein products may result in changes in the matrix
composition and in ECM remodeling. Several factors such as
elevated pressure or mechanical stretching have also been
shown to influence ECM gene expression of the TM in vivo
and in cultured TM cells [13,18]. While the role of matrix
metalloproteases has been well studied in TM remodeling [4,
10], changes in the TM intracellular proteases have been the
subject of scant studies. Cellular proteasome have been found
to undergo oxidative modification, resulting in the impairment
of  their  function  in  the  glaucomatous  TM  [6,19,20].  A
comprehensive  and  quantitative  investigation  of  the  TM
proteasomal activities also remains to be performed.
The  proteomic  analysis  of  clinically  relevant  tissues
requires access to fresh or frozen specimens with adequate
morphological consistency and sufficient quantity as well as
proper and detailed clinical records [21]. The availability of
such  properly  preserved  tissues  is  often  scarce  especially
ocular  tissues.  This  fact  limits  meaningful  outcome  of
proteomic analyses. Obtaining sufficient quantity of different
ocular  tissues  is  important  for  proteomic  and  genomic
analyses, one providing complementary information to the
other. Enrichment of proteins is a necessity due to the tiny
nature of tissue regions in the case of ocular tissues. The TM
is one such region where the availability of the amount of
tissue material from a single donor is often limited (due to the
tiny nature of the region), and without enrichment, successful
identification of protease proteome will be severely limited.
Identification of proteins by mass spectrometry can be
limited  by  several  factors  even  for  very  sensitive  mass
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other,  abundant  proteins  with  similar  isoelectric  points,
overlay by proteins that undergo better digestion and thus
generating peptides in the similar isoelectric point range, and
finally,  peptides  more  susceptible  to  ionization  and  thus
coming in close proximity to mass/charge ratio with respect
to peptides of interest. The reduction of the complexity of the
protein mixture (in protein extracts) is an important aspect in
the  mass  spectrometric  identification  of  proteins.
Immobilized  inhibitor  or  substrate  analog  entrapment  of
enzymes is an important means for enrichment of enzymes
including proteases which reduce complexity while enriching
the proteins. Several other fractionation techniques have been
used in an attempt to reduce the complexity in conjunction
with  affinity  enrichment,  including  2D  blue  native  gel
electrophoresis which resolves protein complexes in a non-
TABLE 2. SELECT PROTEASES AND PROTEINS IDENTIFIED FROM NORMAL TRABECULAR MESHWORK.
Protein Accession
number
Peptide
matches
Peptide
matches
Donors
Alpha-1-antichymotrypsin
precursor
P01011 4 5 6
Alpha-1-antitrypsin
precursor
P01009 4 14 6
Antithrombin-III precursor             P01008 3 2 3
Calpactin I light chain                    P08206 7 1 1
Calpain 1, large [catalytic]
subunit
P07384 7 6 3
Calponin H1, smooth
muscle
P51911 3 1 2
Caspase-14 precursor P31944 6 2 3
Cathepsin D P07339 6 2 2
Ceruloplasmin precursor                P00450 5 5 4
Coagulation factor XIII A
chain
P00488 2 1 1
Complement C3 P01024 4 3 3
Complement C4 precursor             P01028 4 1 2
Complement component 1                  Q07021 3 2 1
Complement factor B
precursor
P00751 3 2 1
Complement factor H
precursor
P08603 3 2 1
Endoplasmin P14625 3 2 3
Neurolysin, mitochondrial Q9BYT8 2 1 2
Prothrombin precursor P00734 2 1 3
Puromycin-sensitive
aminopeptidase
P55786 3 1 1
Tripeptidyl-peptidase II P29144 3 1 1
The proteins that mostly proteases identified by LC MS/MS
of protein extracts were derived from the TM of a 55-year-old
male Caucasian donor after enrichment on an immobilized
immunocolumn and SDS–PAGE fractionation as described in
Methods. 1Swiss-Prot   database  entries  are  shown;  2peptide
matches  in  current  mass  spectrometric  analyses;  3peptide
matches  and  number  of  donors  from  our  previous  TM
proteomic  analyses  [17]  without  affinity  enrichment;
4identified protease inhibitors; 5identified proteins that are not
proteases;  6cathepsin D has been identified as bovine and
human protein in our previous and current TM proteomic
analysis,  here  human  protein  accession  number  has  been
provided;  7not  all  complement  components  possess
proteolytic activity; however, they act as a complex which
results in proteolytic activity, here we have placed them in the
protease category.
denaturing first dimension gel followed by the fractionation
of the complex components in a denaturing second dimension
gel [22].
The immobilized inhibitors or inhibitory peptides have
been  in  use  for  affinity  purification.  Immobilized  peptide
arrays have been used for epitope mapping as well as protein–
protein  interaction,  enzyme-substrate  interaction,  and
enzyme-inhibitor interaction studies [23]. Inhibitor affinity
chromatography,  using  immobilized  substrate  analogs  or
other  inhibitors,  has  been  employed  to  isolate  enzyme
proteomes and is often referred to as the chemiproteomic
approach  [24].  Affinity  enrichment  of  many  different
enzymes  such  as  kinases,  phosphatases,  and  matrix
metalloproteases (MMPs) have benefited from the use of this
approach [24-28]. However, such approaches are yet to be
applied  to  the  comprehensive  enrichment  of  intracellular
proteases,  particularly  in  the  ocular  tissues  [28,29].
Immobilized inhibitors have not only been used for affinity
enrichment  but  also  for  several  other  novel  uses  [30-32].
Surface-immobilized, oriented peptide aptamers have been
used for the detection of specific target proteins in complex
biologic solutions [27]. Aprotinin-linked fibrinogen in a novel
approach has been used for controlling degradation of fibrin
gels [32]. The precursor state of factor Xa heparin-binding
exosite was revealed by Ixolaris binding to factor X in a novel
fashion  [31].  Label-free,  high-throughput  functional  lytic
assays based on immobilized inhibitors or substrates have
made the development of refractive index-sensitive resonant
waveguide  grating  biosensors  possible  [30].  Affinity
enrichment of MMPs is a routine procedure for non-ocular
tissues [28,29]. The approach outlined here can be used in
combination  with  immobilized  MMP  target  peptides  and
immobilized metal and gelatin GQ columns to enable the
capture  of  MMPs  and  their  tissue  inhibitors.  Sequential
capture of matrix and intracellular proteases from the same
tissue  is  possible  by  combination  of  these  techniques,
maximizing  the  utility  of  tissue  toward  comprehensively
discovering changes in the protease proteome composition in
glaucoma (or any other disease) in comparison to the normal
state.  Additives  or  carrier  molecules,  which  are  usually
proteins,  electrolytes,  and  tRNAs,  enhance  recovery  of
biomacromolecules including proteins and DNA [33,34]. The
carrier molecules usually act as chaperones and help entrap
low  amounts  of  protein  following  elution.  Electrolytes
typically  promote  charge-charge  interaction  and  help  in
coagulation  thus  facilitating  enhanced  recovery.  We  have
used two different inhibitor peptide cocktails to determine
whether there are vast differences in their efficiency to capture
target proteins. tRNA was added to enhance the recovery of
proteins while it serves as a carrier molecule during acetone
precipitation.
Compared to our previous analyses [17], current analyses
captured a greater number of protease peptides from a single
TM  sample,  demonstrating  the  utility  and  efficacy  of  the
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1 2 3
3
4
4
4
5
5
6
5
5
5
7
7
5,7
7
7
5fractionation  strategy  presented  here.  Several  serine  and
cysteine proteases have thus been identified (Table 2). In
particular, several complement components have also been
identified. It is important to note that complement components
have been found to impair synapses and have been implicated
in neurodegeneration of retinal ganglion cells, a process that
is  thought  to  occur  in  glaucoma  [35].  Our  analyses  also
revealed the release and capture of mitochondrial neurolysin
and tripeptidyl peptidase II (Table 2). Tripeptidyl peptidase II
is a component of the proteolytic cascade acting downstream
of the 26S proteasome in the ubiquitin-proteasome pathway
[36,37].  Tripeptidyl  peptidase  II  is  thought  to  be  able  to
complement the 26S proteasome function under conditions in
which the latter is inhibited. Therefore, the expression of
tripeptidyl peptidase II in normal TM suggests that perhaps in
at least some eyes, the proteasomal function is impaired long
before  the  pathology  is  apparent.  Our  efforts  to  capture
protease  proteome  in  the  DBA/2J  mouse  model  using
combinatorial affinity enrichment methods outlined above is
under progress to further our understanding of these proteases
and their alterations.
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